Immunotherapy for lung cancer. - Wikidata - wikimedia - TriplyDB

Immunotherapy for lung cancer.

Immunotherapy for lung cancer.

http://www.wikidata.org/entity/Q41916016

about

Evaluation of 29 indicators for the prognosis of advanced non-small cell lung cancer with cytokine-induced killer cell therapy combined with chemotherapy

P2860

Q36824656-9FBFF0ED-E57C-4F96-B268-17DC0B17F700

P2860

Immunotherapy for lung cancer.

http://www.wikidata.org/entity/Q41916016

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Immunotherapy for lung cancer.

@en

type

label

Immunotherapy for lung cancer.

@en

prefLabel

Immunotherapy for lung cancer.

@en

P1433

Q41916016-D05CA48B-8D60-4F0B-A1BA-BB1D5BE8FE43

P1476

Q41916016-4B7C2B86-3557-4287-ABBF-7F54FE3496C6

P2093

Q41916016-06082F94-8B88-49C2-B30F-0876AFE5AA06

P2860

Q41916016-00252614-8824-4BC3-907B-CCDA5C87C289

Q41916016-040DDC9B-67B2-496F-AC09-731025B7851A

Q41916016-110FE8AF-B366-477A-99A0-19717579A389

Q41916016-2CF86C43-6C30-4B05-920A-C724CBCB4C9C

Q41916016-31D6746D-0186-476D-A3C8-99E07FB52413

Q41916016-31FF78E6-608D-4BF6-AD15-BD5402F039B4

Q41916016-6FB9B69A-2E33-42D8-ABB0-3C9241FF5E71

Q41916016-7BF27A56-1E5A-46F9-B40B-08FA0C6BB33B

Q41916016-7C5AC75F-C773-4A5C-9166-08E8A4345B8A

Q41916016-7CD90317-8565-4762-B2D4-C6978260101B

P304

Q41916016-C419682B-9591-47D7-B849-10817C80C00D

P31

Q41916016-F4E579CD-AEEA-4F8B-8156-5CD18C6083D3

P356

Q41916016-4ECA6F6E-468E-4A96-82D7-B7A73FB0CAE2

P433

Q41916016-01122169-39E8-481B-820A-0E4B7A603B90

P478

Q41916016-A1891D02-F078-4CFA-9CA6-2F13B0E1563C

P577

Q41916016-FB38DB23-8890-45C4-9FD9-E3C142CA4A53

P698

Q41916016-C20452FB-CA25-485B-A85B-82CC862663ED

P921

Q41916016-DB97CFDF-02EB-46E6-9B88-CFA0BF54487C

P932

Q41916016-D53F3BC6-8F7D-4B50-9435-6E6ECE237CA1

P356

J.ISSN.2218-6751.2015.12.07

P1433

Translational lung cancer research

P1476

Immunotherapy for lung cancer.

@en

P2093

María González-Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Improved endpoints for cancer immunotherapy trials

Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer

Blockade of the B7-H1/PD-1 pathway for cancer immunotherapy

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Pembrolizumab for the treatment of non-small-cell lung cancer

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection

EGFR T790M mutation as a possible target for immunotherapy; identification of HLA-A*0201-restricted T cell epitopes derived from the EGFR T790M mutation

PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis

P304

675-677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2218-6751.2015.12.07

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26798576

http://www.w3.org/2001/XMLSchema#string

P921

P932

4700218

http://www.w3.org/2001/XMLSchema#string